Platelets
drugOn this page
Also known as Homo sapiens plateletallogenicHuman plateletPlatelets allogenicPlatelets human allogenic
Summary
Platelets (CHEMBL2108632) is a phase-3 clinical-stage unknown; indicated across 10 conditions including injury and palmar fibromatosis.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 10 conditions
- Clinical trials: 21
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108632 |
| Name | Platelets |
| Type | Unknown |
| Max phase | 3 |
Also known as: Homo sapiens platelet, allogenic, Human platelet, Platelets, Platelets allogenic, Platelets human allogenic, PLATELETS
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
10 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| injury | 3 | MONDO:0021178 | EFO:0000546 |
| palmar fibromatosis | 2 | MONDO:0006345 | EFO:0004229 |
| thrombocytopenia | 2 | MONDO:0002049 | HP:0001873 |
| stroke disorder | 2 | MONDO:0005098 | EFO:0000712 |
| brain injury | 2 | MONDO:0043510 | MONDO:0043510 |
| osteoarthritis, knee | 2 | MONDO:0005416 | EFO:0004616 |
| osteoarthritis | 1 | MONDO:0005178 | MONDO:0005178 |
3 further indication records had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 21.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 14 |
| PHASE3 | 3 |
| PHASE2 | 2 |
| PHASE4 | 1 |
| PHASE2/PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06613425 | PHASE4 | RECRUITING | Clinical Study of Combined Platelet Transfusion |
| NCT03991481 | PHASE3 | ACTIVE_NOT_RECRUITING | The Cryopreserved vs. Liquid Platelets Trial |
| NCT04704869 | PHASE3 | COMPLETED | Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation |
| NCT04709705 | PHASE2/PHASE3 | COMPLETED | DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS) |
| NCT05502809 | PHASE3 | UNKNOWN | Frozen Platelets in the Treatmentof Traumatic or Vascular Bleeding |
| NCT01135862 | PHASE2 | UNKNOWN | Platelet Administration To Patients With Traumatic Brain Injury Who Were Treated With Aspirin |
| NCT01283321 | PHASE2 | TERMINATED | RiaSTAP vs. Conventional Transfusion in Patients Having Heart Valve Surgery |
| NCT04201704 | Not specified | RECRUITING | Effect of Giving Reduced Fluid in Children After Trauma |
| NCT05713734 | Not specified | RECRUITING | Bleeding of Unknown Cause: a Swiss Case-control Study |
| NCT06601894 | Not specified | NOT_YET_RECRUITING | The Relationship of Platelet Counts With Sickle Cell Anemia in the Eastern Region of Saudi Arabia |
| NCT06623084 | Not specified | NOT_YET_RECRUITING | Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS) |
| NCT00537784 | Not specified | COMPLETED | Platelet Concentrate in Achilles Tendon Repair |
| NCT00699621 | Not specified | UNKNOWN | Platelet Transfusion in Acute Intracerebral Hemorrhage |
| NCT01534117 | Not specified | COMPLETED | Platelet Function Analysis in Head Trauma: ASA/Plavix |
| NCT01810276 | Not specified | TERMINATED | Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury |
| NCT02305732 | Not specified | COMPLETED | A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components |
| NCT02689232 | Not specified | COMPLETED | TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed. |
| NCT02721940 | Not specified | UNKNOWN | Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis |
| NCT02906878 | Not specified | UNKNOWN | Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter |
| NCT03784794 | Not specified | COMPLETED | Patient Blood Management for Massive Obstetric Hemorrhage |
| NCT06043050 | Not specified | COMPLETED | PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: injury